Heligenics key facts
as of Oct 2026- Developer of a medicinal drug designed to prevent disease and heal patients afflicted with illness through genomics.
- Heligenics is valued at approximately $17.2M as of Oct 2026 (last reported valuation).
- It has raised $6.0M across 3 recorded rounds; the latest was Seed Round ($2.6M) in Aug 2024.
- Notable investors include Battle Born Venture, City of Las Vegas, Las Vegas Foundation, Nevada Governor's Office of Economic Development, University of Nevada.
- Heligenics has filed 3 Form Ds with the SEC since 2020, most recently Jan 2025 ($2.6M sold to 8 investors).
- Status: Privately Held (backing).
Heligenics's last reported valuation, Aug 2022. Nothing priced has surfaced since.
- ·Watch Heligenics: the Monday email on marks, rounds and moves
Heligenics funding rounds
3 roundsHeligenics valuation
Heligenics's last reported valuation was $17.2 million in Aug 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Heligenics raised?
Heligenics has raised $6 million across 3 recorded rounds since 2020. The largest was a $2.6 million seed round in Aug 2024.
Heligenics has filed 3 Form Ds with the SEC since 2020, most recently in Jan 2025 ($2.6 million sold to 8 investors).
Heligenics investors
5 investors are on record for Heligenics, including Battle Born Venture, City of Las Vegas, Las Vegas Foundation and Nevada Governor's Office of Economic Development. The seed round in Aug 2024 drew 8 investors.
About Heligenics
Developer of a medicinal drug designed to prevent disease and heal patients afflicted with illness through genomics. The company offers a genetic testing and drug discovery by determining the function of genetic variation and can comprehensively measure the functional significance of naturally occurring mutations in the human genome, enhancing the accuracy of genetic testing whether for rare diseases or cancer, enabling the medical industry to get an improve genetic test interpretation and the pharmaceutical companies to empower conversion of generic drugs into targeted precision medicines.
- Sector
- Healthcare
- HQ
- Las Vegas, NV, United States
- Founded
- 2015
- Employees
- 7
- Website
- heligenics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.